Moderate elevation of serum CA 19-9 is unfavorable prognostic factor for patients with pancreatic ductal adenocarcinoma after radical rescection

Yiran ZHOU,Baiyong SHEN

DOI: https://doi.org/10.16139/j.1007-9610.2016.06.013

2016-01-01

Abstract:Objective To investigate the prognostic effect of serum CA 19-9 level on the patients with pancreatic ductal adenocarcinoma after radical rescection. Methods The clinical data including follow-up of 240 patients with pancreatic ductal adenocarcinoma after R0 rescection from January 2003 to December 2014 in Ruijin Hospital were retrospectively analyzed. The patients were divided into 5 groups based on preoperative serum CA 19-9 level including normal group (5.0-34.9 U/mL), mild elevation group (35.0-99.9 U/mL), moderate elevation group (100.0-599.9 U/mL), severe elevation group (≥600.0 U/mL) and negative group (<5.0 U/mL). Kaplan-Meier survival analysis was used to access the prognosis of patients in 5 groups. Results The shortest survival time was found in the patients with moderate elevation of preoperative CA 19-9 which was present with significant differences when excluding the patients with total bilirubin ≥10 mg/dL. Conclusions It was suggested in this study that the unfavorable prognostic factor is moderate elevation of preoperative serum CA 19-9 level (100.0-599.9 U/mL) in the patients with pancreatic ductal adenocarcinoma after radical rescection but not severe elevated (≥600.0 U/mL).